Abstract
Background
Most materials used clinically for filling severe bone defects either cannot induce bone re-generation or exhibit low bone conversion, therefore, their therapeutic effects are limited. Human umbilical cord mesenchymal stem cells (hUC-MSCs) exhibit good osteoinduction. However, the mechanism by which combining a heterogeneous bone collagen matrix with hUC-MSCs to repair the bone defects of alveolar process clefts remains unclear.
Methods
A rabbit alveolar process cleft model was established by removing the bone tissue from the left maxillary bone. Forty-eight young Japanese white rabbits (JWRs) were divided into normal, control, material and MSCs groups. An equal volume of a bone collagen matrix alone or combined with hUC-MSCs was implanted in the defect. X-ray, micro-focus computerized tomography (micro-CT), blood analysis, histochemical staining and TUNEL were used to detect the newly formed bone in the defect area at 3 and 6 months after the surgery.
Results
The bone formation rate obtained from the skull tissue in MSCs group was significantly higher than that in control group at 3 months (P < 0.01) and 6 months (P < 0.05) after the surgery. The apoptosis rate in the MSCs group was significantly higher at 3 months after the surgery (P < 0.05) and lower at 6 months after the surgery (P < 0.01) than those in the normal group.
Conclusions
Combining bone collagen matrix with hUC-MSCs promoted the new bone regeneration in the rabbit alveolar process cleft model through promoting osteoblasts formations and chondrocyte growth, and inducing type I collagen formation and BMP-2 generation.
Graphical abstract
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
Abbreviations
- JWRs:
-
Japanese white rabbits
- hUC-MSCs:
-
Human umbilical cord mesenchymal stem cells
- micro-CT:
-
Micro focus computerized tomography
- HE:
-
Hematoxylin eosin
- ALP:
-
Alkaline phosphatase
- PAS:
-
Periodic acid-Schiff stain
- IHC:
-
Immunohistochemical
- TUNEL:
-
TdT-mediated dUTP nick-end Labelling
- BGP:
-
Bone Gla protein
References
Cohen, M., Figueroa, A. A., Haviv, Y., Schafer, M. E., & Aduss, H. (1991). Iliac versus cranial bone for secondary grafting of residual alveolar clefts. Plastic and Reconstructive Surgery, 87(3), 423–427.
Tai, C. C., Sutherland, I. S., & McFadden, L. (2000). Prospective analysis of secondary alveolar bone grafting using computed tomography. Journal of Oral and Maxillofacial Surgery, 58(11), 1241–1249.
LaRossa, D., Buchman, S., Rothkopf, D. M., Mayro, R., & Randall, P. (1995). A comparison of iliac and cranial bone in secondary grafting of alveolar clefts. Plastic and Reconstructive Surgery, 96(4), 789–797.
Rosenthal, R. K., Folkman, J., & Glowacki, J. (1999). Demineralized bone implants for nonunion fracture, bone cysts, and fibous lesins. Clinical Orthopaedics and Related Research, 364, 61–69.
Al-Asfour, A., Farzad, P., Andersson, L., Joseph, B., & Dahlin, C. (2014). Host tissue reactions of non-demineralized autogenic and xenogenic dentin blocks implanted in a non-osteogenic environment. An experimental study in rabbits. Dental Traumatology, 30(3), 198–203.
Smith, B. T., Santoro, M., Grosfeld, E. C., Shah, S. R., van den Beucken, J. J. J. P., Jansen, J. A., & Mikos, A. G. (2017). Corporation of fast dissolving glucose porogens into an injectable calcium phosphate cement for bone tissue engineering. Acta Biomaterialia, 50, 68–77.
Liu, S., Hou, K. D., Yuan, M., Peng, J., Zhang, L., Sui, X., Zhao, B., Xu, W., Wang, A., Lu, S., & Guo, Q. (2014). Characteristics of mesenchymal stem cells derived from Wharton’s jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage. Journal of Bioscience and Bioengineering, 117(2), 229–235.
Tassi, S. A., Sergio, N. Z., Misawa, M. Y. O., & Villar, C. C. (2017). Efficacy of stem cells on periodontal regeneration: Systematic review of pre-clinical studies. Journal of Periodontal Research, 52(5), 793–812.
Jin, Y. Z., & Lee, J. H. (2018). Mesenchymal stem cell therapy for bone regeneration. Clinics in Orthopedic Surgery, 10(3), 271–278.
Hämmerle, C. H., Chiantella, G. C., Karring, T., & Lang, N. P. (1998). The effect of a deproteinized bovine bone mineral on bone regeneration around titanium dental implants. Clinical Oral Implants Research, 9(3), 151–162.
Lee, J. S., Wikesjö, U. M., Jung, U. W., Choi, S. H., Pippig, S., Siedler, M., & Kim, C. K. (2010). Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a beta-tricalcium phosphate carrier into one-wall intrabony defects in dogs. Journal of Clinical Periodontology, 37(4), 382–389.
Liu, Y., Zheng, Y., Ding, G., Fang, D., Zhang, C., Bartold, P. M., Gronthos, S., Shi, S., & Wang, S. (2008). Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine. Stem Cells, 26(4), 1065–1073.
Schmitz, J. P., & Hollinger, J. O. (1986). The critical size defect as an experimental model for craniomandibulofacial nonunions. Clinical Orthopaedics and Related Research, 205, 299–308.
Gallego, L., Junquera, L., García, E., García, V., Alvarez-Viejo, M., Costilla, S., Fresno, M. F., & Meana, A. (2010). Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. Tissue Engineering Part A, 16(4), 1179–1187.
Korn, P., Hauptstock, M., Range, U., Kunert-Keil, C., Pradel, W., Lauer, G., & Schulz, M. C. (2017). Application of tissue-engineered bone grafts for alveolar cleft osteoplasty in a rodent model. Clinical Oral Investigations, 21(8), 2521–2534.
Jahanbin, A., Rashed, R., Alamdari, D. H., Koohestanian, N., Ezzati, A., Kazemian, M., Saghafi, S., & Raisolsadat, M. A. (2016). Success of maxillary alveolar defect repair in rats using osteoblast-differentiated human deciduous dental pulp stem cells. Journal of Oral and Maxillofacial Surgery, 74(4), 829.e1–9.
Kandalam, U., Kawai, T., Ravindran, G., Brockman, R., Romero, J., Munro, M., Ortiz, J., Heidari, A., Thomas, R., Kuriakose, S., Naglieri, C., Ejtemai, S., & Kaltman, S. I. (2021). Predifferentiated gingival stem cell-induced bone regeneration in rat alveolar bone defect model. Tissue Engineering Part A, 27(5–6), 424–436.
Toyota, A., Shinagawa, R., Mano, M., Tokioka, K., & Suda, N. (2021). Regeneration in experimental alveolar bone defect using human umbilical cord mesenchymal stem cells. Cell Transplantation, 30, 963689720975391.
Sun, X. C., Zhang, Z. B., Wang, H., Li, J. H., Ma, X., & Xia, H. F. (2019). Comparison of three surgical models of bone tissue defects in cleft palate in rabbits. International Journal of Pediatric Otorhinolaryngology, 124, 164–172.
Esteban, J. M., Ahn, C., Mehta, P., & Battifora, H. (1994). Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. American Journal of Clinical Pathology, 102(2), 158–162.
Xavier, L. L., Viola, G. G., Ferraz, A. C., Da, C. C., Deonizio, J. M., Netto, C. A., & Achaval, M. (2005). A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Research. Brain Research Protocols, 16(1–3), 58–64.
Zhang, L., Li, Y., Guan, C. Y., Tian, S., Lv, X. D., Li, J. H., Ma, X., & Xia, H. F. (2018). Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase. Stem Cell Research & Therapy, 9(1), 36.
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Dj, P., & Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317.
Gimbel, M., Ashley, R. K., Sisodia, M., Gabbay, J. S., Wasson, K. L., Heller, J., Wilson, L., Kawamoto, H. K., & Bradley, J. P. (2007). Repair of alveolar cleft defects: Reduced morbidity with bone marrow stem cells in a resorbable matrix. The Journal of craniofacial surgery, 18(4), 895–901.
Xu, Y., Meng, H., Li, C., Hao, M., Wang, Y., Yu, Z., Li, Q., Han, J., Zhai, Q., & Qiu, L. (2010). Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization. Stem Cells and Development, 19(10), 1511–1522.
Wang, N., Xiao, Z., Zhao, Y., Wang, B., Li, X., Li, J., & Dai, J. (2018). Collagen scaffold combined with human umbilical cord-derived mesenchymal stem cells promote functional recovery after scar resection in rats with chronic spinal cord injury. Journal of Tissue Engineering and Regenerative Medicine, 12(2), e1154–e1163.
Cao, F. J., & Feng, S. Q. (2009). Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chinese Medical Journal (England), 122(2), 225–231.
Baksh, D., Yao, R., & Tuan, R. S. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25(6), 1384–1392.
Wang, L., Tran, I., Seshareddy, K., Weiss, M. L., & Detamore, M. S. (2009). A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Engineering Part A, 15(8), 2259–2266.
Ding, D. C., Chang, Y. H., Shyu, W. C., & Lin, S. Z. (2015). Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy. Cell Transplantation, 24(3), 339–347.
De Miguel, M. P., Fuentes-Julián, S., Blázquez-Martínez, A., Pascual, C. Y., Aller, M. A., Arias, J., & Arnalich-Montiel, F. (2012). Immunosuppressive properties of mesenchymal stem cells: Advances and applications. Current Molecular Medicine, 12(5), 574–591.
Takushima, A., Kitano, Y., & Harii, K. (1998). Osteogenic potential of cultured periosteal cells in a distracted bone gap in rabbits. The Journal of Surgical Research, 78(1), 68–77.
Barry, F. P., & Murphy, J. M. (2004). Mesenchymal stem cells: Clinical applications and biological characterization. The International Journal of Biochemistry & Cell Biology, 36(4), 568–584.
Hollinger, J. O., Schmitt, J. M., Buck, D. C., Shannon, R., Joh, S. P., Zegzula, H. D., & Wozney, J. (1998). Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. Journal of Biomedical Materials Research, 43(4), 356–364.
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008). Wound repair and regeneration. Nature, 453(7193), 314–321.
Kugimiya, F., Kawaguchi, H., Kamekura, S., Chikuda, H., Ohba, S., Yano, F., Ogata, N., Katagiri, T., Harada, Y., Azuma, Y., Nakamura, K., & Chung, U. I. (2005). Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. Journal of Biological Chemistry, 280(42), 35704–35712.
Wang, Q., Huang, C., Xue, M., & Zhang, X. (2011). Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone, 48(3), 524–532.
Tilly, J. L., Tilly, K. I., & Perez, G. I. (1997). The genes of cell death and cellular susceptibility to apoptosis in the ovary: A hypothesis. Cell Death and Differentiation, 4(3), 180–187.
Takamoto, N., Leppert, P. C., & Yu, S. Y. (1998). Cell death and proliferation and its relation to collagen degradation in uterine involution of rat. Connective Tissue Research, 37(3–4), 163–175.
Pellicciari, C., Bottone, M. G., Schaack, V., Barni, S., & Manfredi, A. A. (1996). Spontaneous apoptosis of thymocytes is uncoupled with progression through the cell cycle. Experimental Cell Research, 229(2), 370–377.
Schlagheck, M. L., Walzik, D., Joisten, N., Koliamitra, C., Hardt, L., Metcalfe, A. J., Wahl, P., Bloch, W., Schenk, A., & Zimmer, P. (2020). Cellular immune response to acute exercise: Comparison of endurance and resistance exercise. European Journal of Haematology., 105(1), 75–84.
Clyne, B., & Olshaker, J. S. (1999). The C-reactive protein. The Journal of Emergency Medicine, 17(6), 1019–1025.
Su, R. C., Lad, A., Breidenbach, J. D., Kleinhenz, A. L., & Kennedy, D. J. (2020). Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-lr (mc-lr) hepatotoxicity. Chemosphere, 257, 127111.
StPán, J., Pilarová, T., Votrubová, O., & Melicharová, D. (1974). Serum alkaline phosphatase as indicator of the liver and bone involvement in patients treated by chronic dialysis. Casopís Lékar Ceskych, 113(31), 952–957.
Li, Y. C., Shen, J. D., Lu, S. F., Zhu, L. L., Wang, B. Y., Bai, M., & Xu, E. P. (2020). Transcriptomic analysis reveals the mechanism of sulfasalazine-induced liver injury in mice. Toxicology Letters, 321, 12–20.
Kotobuki, N., Katsube, Y., Katou, Y., Tadokoro, M., Hirose, M., & Ohgushi, H. (2008). In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs). Cell Transplantation, 17(6), 705–712.
An, J. H., Park, H., Song, J. A., Ki, K. H., Yang, J. Y., Choi, H. J., Cho, S. W., Kim, S. W., Kim, S. Y., Yoo, J. J., Baek, W. Y., Kim, J. E., Choi, S. J., Oh, W., & Shin, C. S. (2013). Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice. Tissue Engineering Part A, 19(5–6), 685–696.
Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109(12), 1543–1549.
Linero, I., & Chaparro, O. (2014). Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS ONE, 9(9), e107001.
Acknowledgements
The authors are very grateful to the National Key Research and Development Program of China We are also very grateful to the animal experiment center of the National Research Institute for Family Planning for its meticulous care of animals.
Funding
This work was funded by grants from the National Key Research and Development Program of China (Grant No. 2016YFC1000803).
Author information
Authors and Affiliations
Contributions
XCS, XM and HFX designed the study. XCS, HW and JHL were responsible for the vivo surgery and performing the procedure. YFY and LQY provided the bone repair materials. HW and DZ were responsible for in vitro experiments. XCS, HW and HFX prepared the manuscript. XCS, HW, DZ and HFX were responsible for revising the manuscript critically for important intellectual content. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical Approval
Ethical approval to report this case was obtained from the National Research Institute for Family Planning (Ethics Number 2015-16).
Consent for Publication
All authors gave consent for publication.
Informed Consent
There are no human subjects in this article and informed consent is not applicable.
Research involving Human and Animal Rights
All procedures in this study were conducted in accordance with the National Research Institute for Family Planning (Ethics Number 2015-16) approved protocols.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sun, XC., Wang, H., Zhang, D. et al. Combining Bone Collagen Matrix with hUC-MSCs for Application to Alveolar Process Cleft in a Rabbit Model. Stem Cell Rev and Rep 19, 133–154 (2023). https://doi.org/10.1007/s12015-021-10221-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-021-10221-y